Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial electron transport chain (ETC) Coenzyme Q (CoQ) pool and its associated complexes (Complex I, II, and III) constitute a critical functional unit for cellular energy production and redox homeostasis (StatPearls: Coenzyme Q10). Coenzyme Q, or ubiquinone, acts as a mobile, lipophilic electron carrier that shuttles electrons from NADH:ubiquinone oxidoreductase (Complex I) and succinate dehydrogenase (Complex II) to ubiquinol-cytochrome c reductase (Complex III) (UniProt: P03886, P00156). This electron transfer is coupled to the translocation of protons across the inner mitochondrial membrane, generating the electrochemical gradient required for ATP synthesis via oxidative phosphorylation. Beyond its role in energy metabolism, the CoQ pool serves as a vital antioxidant, protecting mitochondrial lipids from oxidative damage and modulating the mitochondrial permeability transition pore (PubMed: 29165315). Dysfunction within this system is central to the pathogenesis of primary mitochondrial diseases, such as Leber's hereditary optic neuropathy (LHON), and is implicated in neurodegenerative conditions like Parkinson's disease and cardiovascular dysfunction (NIH: Mitochondrial Diseases). Therapeutic approaches include the use of CoQ10 supplements and synthetic analogs like idebenone to restore electron flow, while specific inhibitors like metformin or atovaquone target these complexes for metabolic or anti-infective purposes.
Facilitation of electron transfer within the respiratory chain, antioxidant protection of mitochondrial membranes, and targeted inhibition of respiratory complexes to modulate metabolic activity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial electron transport chain Coenzyme Q pool and associated complexes (ETC CoQ pool).